|
a) Countries where the systems operate
|
|
b) The extent of data collection (e.g. community services, facilities services)
|
|
c) The main purpose of the system d) Records linkage
|
|
e) The level of implementation (e.g. local, national)
|
|
f) Target population (e.g. specified subgroups or total population)
|
|
g) The data collection form used (e.g. electronic, paper)
|
|
h) Whether the data entered into the registry was primary data, or if the registry was based on secondary data from pre-existing sources.
|
|
i) MNCHcare periods that the system registers
|
|
j) Whether it collects the MNCH variables defined by the GAIA project
|
|
k) Whether it collects socio-demographic data, obstetric information, pre-existing conditions of each women, and antenatal care outcome process.
|
|
l) Type of code for classification of diseases used
|
|
m) The individual data capture process (how and where it is done)
|
|
n) Baseline data (pregnancy and outcomes) timeframe
|
|
o) Capability to import, compile and export electronic data.
|
|
p) Capability to link individual MNCH data with other registers(e.g. laboratory records, expense drug records, vaccine registers)
|
|
q) Type of monitoring to assess data quality
|
|
r) Whether it has a back-up policy.
|
|
s) Availability of data collection tools and system documentation
|
|
t) Maintenance and update process
|
|
u) Whether it has data access policies,
|
|
v) Type of privacy protection
|
|
w) Funding or sponsor of each system
|
|
x) Prior use in active surveillance or pharmacovigilance or post-marketing surveillance.
|
